Gabapentin
Product Images NDC 68151-1028

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68151-1028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 1028)

This is a description of a medication called Gabapentin. It comes in a capsule form that contains 100 milligrams of the drug. The manufacturer of the drug is Apotex and the lot number of the medicine is MM9354. The expiration date of the medicine is October 2016. It also contains a code - W042216SN2. Lastly, it is a prescription medication and should only be taken with a valid prescription from a doctor (RX only).*

FDA Label Image

Figure1 (Figure1)

This is a graph that represents the mean pain score over a 4-week dose titration period and a 4-week fixed dose period. It compares the pain score between a placebo and Gabapentin at 3600 mg/day. The pain scores were recorded on a scale of 0-10. The graph shows a gradual decrease in pain score over time with Gabapentin, and a comparatively constant pain score with the placebo. There are baseline and 8 weeks readings.*

FDA Label Image

Figure2 (Figure2)

The text describes a clinical trial of a medication. The trial had a 3-week dose titration period followed by a 4-week fixed dose period. The medication being evaluated is Gabapentin, given at a daily dose of either 1800mg or 2400mg, while the placebo group got no medication. The study evaluated the effect of the medication on pain and presents a mean pain score over the weeks. The graph depicts the baseline and pain scores over the seven weeks of the study.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Scale (Scale)

This appears to be a formula for estimating creatinine clearance (CLCr) based on age and serum creatinine levels. However, some characters in the formula are not readable which makes it difficult to provide an accurate description.*

FDA Label Image

Structuralformula (Structuralformula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.